AI-Powered Stroke Diagnosis System Receives CE Mark, Aims to Expand Access to Life-Saving Treatment
Table of Contents
A new artificial intelligence (AI)-powered system for rapidly diagnosing stroke has received CE marking, paving the way for wider use across Europe. Developed by Lithuanian company Sentante,the system analyzes brain scans to quickly identify large vessel occlusions (LVOs) – a severe type of stroke where a major artery in the brain is blocked – and determine patient suitability for thrombectomy,a mechanical clot removal procedure. this technology promises to accelerate stroke diagnosis and treatment, potentially improving outcomes for patients.
The Challenge of Rapid Stroke Diagnosis
Stroke is a leading cause of death and disability worldwide. rapid diagnosis and treatment are critical; the faster a blocked artery is opened,the more brain tissue can be saved. However, interpreting brain scans to identify LVOs requires specialized expertise, and access to neurologists trained in stroke imaging can be limited, particularly in smaller hospitals or rural areas. This delay in diagnosis can significantly reduce the chances of a triumphant outcome.
According to the latest data from the Sentinel Stroke National Audit Programme (SSNAP) in the UK,only 3.9% of all stroke patients received a thrombectomy in the year to march 2024. https://qip.org.uk/wp-content/uploads/2024/11/Ref.-466-SSNAP-Annual-report-2024-FINAL.pdf this highlights the need for tools that can extend the reach of specialized expertise.
how Sentante’s AI System works
Sentante’s AI system, which has not been publicly named beyond its association with the company, analyzes CT perfusion scans – a type of imaging that shows blood flow in the brain – to identify LVOs and assess the extent of potentially salvageable brain tissue (the penumbra). The system then provides clinicians with a rapid assessment, helping them quickly determine if a patient is likely to benefit from thrombectomy.
“sometimes, the future is way closer then we think,” said Edvardas Satkauskas, CEO of Sentante, in a statement to BBC News.
The CE mark signifies that the system meets the safety, health, and environmental protection requirements of the European Union, allowing it to be marketed and used in clinical settings across Europe.
Benefits of AI in Stroke Care
The integration of AI into stroke care offers several potential benefits:
* Faster Diagnosis: AI can analyze scans much faster than a human radiologist, reducing the time to diagnosis.
* Increased Access to Expertise: The system can bring specialized stroke imaging expertise to hospitals that may not have immediate access to neurologists.
* Improved patient Selection: AI can help identify patients who are most likely to benefit from thrombectomy, optimizing treatment decisions.
* Reduced Costs: By streamlining the diagnostic process, AI could potentially reduce healthcare costs associated with stroke care.
Future implications and Ongoing research
The CE marking for Sentante’s system represents a significant step forward in the application of AI to stroke care.As AI technology continues to evolve, we can expect to see even more sophisticated tools emerge that further improve stroke diagnosis, treatment, and rehabilitation.
Ongoing research is focused on:
* Expanding AI applications: Developing AI algorithms to predict stroke risk, personalize treatment plans, and monitor patient recovery.
* Improving AI accuracy: Refining AI models to minimize false positives and false negatives.
* Integrating AI into clinical workflows: Seamlessly integrating AI tools into existing hospital systems and clinical workflows.
Key Takeaways:
* A new AI-powered stroke diagnosis system from Sentante has received CE marking for use in Europe.
* The system analyzes brain scans to quickly identify large vessel occlusions and assess suitability for thrombectomy.
* Only 3.9% of stroke patients in the UK received thrombectomy in the year to March 2024, highlighting the need for improved access to this life-saving treatment.
* AI has the potential to significantly improve stroke care by accelerating diagnosis, increasing access to expertise, and optimizing treatment decisions.